SpectraCure Overview
- Founded
-
2003
- Status
-
Public
- Employees
-
17
- Stock Symbol
-
SPEC
- Investments
-
1
- Share Price
-
$0.35
- (As of Tuesday Closing)
SpectraCure General Information
Description
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Contact Information
Primary Industry
Therapeutic Devices
Stock Exchange
STO
Primary Office
- Gasverksgatan 1
- 222 29 Lund
- Sweden
+46 046-16 00 00
SpectraCure Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.35 | $0.35 | $0.28 - $1.20 | $34.4M | 97.1M | 161K | -$0.03 |
SpectraCure Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 61,252 | 48,192 | 181,329 | 244,466 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (2,532) | (2,405) | (1,414) | (1,211) |
| Net Income | (2,710) | (2,718) | (1,671) | (1,447) |
| Total Assets | 17,144 | 21,052 | 25,665 | 10,716 |
| Total Debt | 382 | 542 | 654 | 718 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
SpectraCure Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SpectraCure Patents
SpectraCure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3915463-A4 | System and method for distributing radiation for diagnostics | Pending | 29-May-2020 | 0000000000 | |
| EP-3915463-A1 | System and method for distributing radiation for diagnostics | Pending | 29-May-2020 | 0000000000 | |
| CA-3135863-A1 | System and method for determining light attenuation at optical members inserted in tissue | Pending | 04-Apr-2019 | 0000000000 | |
| EP-3946573-A1 | System and method for determining light attenuation at optical members inserted in tissue | Active | 04-Apr-2019 | 0000000000 | |
| US-11331512-B2 | System and method for determining light attenuation at optical members inserted in tissue | Active | 04-Apr-2019 | A61N5/0601 | 0 |
SpectraCure Executive Team (7)
SpectraCure Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jesper Freij | SpectraCure | Board Member | 000 0000 |
| Katarina Svanberg Ph.D | Self | Board Member | 000 0000 |
| Masoud Khayyami Ph.D | Self | Board Member | 000 0000 |
SpectraCure Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
SpectraCure Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000000 | 07-Apr-2008 | 000000000 | Buildings and Property |